A combination of two GH secretagogues studied for synergistic stimulation of growth hormone release. CJC-1295 (No DAC / MOD GRF 1-29) binds GHRH receptors with a short half-life mimicking natural pulsatile GH secretion. Ipamorelin is a selective ghrelin receptor agonist with minimal cortisol or prolactin side effects in animal models. Together they are studied for…
A synthetic analog of growth hormone-releasing hormone (GHRH) studied for its selective stimulation of GH secretion from the pituitary gland. Research has examined its effects on visceral fat reduction, metabolic markers, and GH/IGF-1 axis modulation. Clinically approved for HIV-associated lipodystrophy; studied more broadly for its metabolic and body composition effects. For research use only.
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.